Average weight of seminal vesicles: An adjustment factor for radical prostatectomy specimens weighed with seminal vesicles

International Journal of Surgical Pathology

Volumn 23, Issue 8, 2015, Pages 617-622

  Tjionas, George A ^a   Epstein, Jonathan I ^b   Williamson, Sean R ^c   Diaz, Mireya ^c   Menon, Mani ^c   Peabody, James O ^c   Gupta, Nilesh S ^c   Parekh, Dipen J ^a   Cote, Richard J ^a   Jorda, Merce ^a   Kryvenko, Oleksandr N ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

prostate; PSA density; retrospective; seminal vesicles; weight

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CALIBRATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT PARAMETERS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE VOLUME; PROSTATE WEIGHT; PROSTATECTOMY; RETROSPECTIVE STUDY; SEMINAL VESICLE; SEMINAL VESICLE WEIGHT; MIDDLE AGED; ONCOLOGY; ORGAN SIZE; PATHOLOGY; PROSTATE; PROSTATE TUMOR; STANDARDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; ORGAN SIZE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEMINAL VESICLES;

EID: 84947420608     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896915600519     Document Type: Article

References (17)

1. Epstein JI, Walsh PC, Carmichael M, Brendler CB,. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994; 271: 368-374.
2. Kryvenko ON, Carter HB, Trock BJ, Epstein JI,. Biopsy criteria for determining appropriateness for active surveillance in the modern era. Urology. 2014; 83: 869-874.
3. Sundi D, Kryvenko ON, Carter HB, Ross AE, Epstein JI, Schaeffer EM,. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men. J Urol. 2014; 191: 60-67.
4. Swanson GP, Epstein JI, Ha CS, Kryvenko ON,. Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens. Prostate. 2015; 75: 424-429.
5. Varma M, Morgan JM,. The weight of the prostate gland is an excellent surrogate for gland volume. Histopathology. 2010; 57: 55-58.
6. Samaratunga H, Montironi R, True L, et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol. 2011; 24: 6-15.
7. Schned AR, Wheeler KJ, Hodorowski CA, et al. Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol. 1996; 20: 1501-1506.
8. Jonmarker S, Valdman A, Lindberg A, Hellstrom M, Egevad L,. Tissue shrinkage after fixation with formalin injection of prostatectomy specimens. Virchows Arch. 2006; 449: 297-301.
9. Lukacs S, Vale J, Mazaris E,. Difference between actual vs. pathology prostate weight in TURP and radical robotic-assisted prostatectomy specimen. Int Braz J Urol. 2014; 40: 823-827.
10. Gofrit ON, Zorn KC, Taxy JB, Zagaja GP, Steinberg GD, Shalhav AL,. The dimensions and symmetry of the seminal vesicles. J Robotic Surg. 2009; 3: 29-33.
11. Kryvenko ON, Epstein JI, Meier FA, Gupta NS, Menon M, Diaz M,. Correlation of high body mass index with more advanced localized prostate cancer at radical prostatectomy is not reflected in PSA level and PSA density but is seen in PSA mass. Am J Clin Pathol. 2015; 144: 271-277.
12. Jeong CW, Park HK, Hong SK, Byun SS, Lee HJ, Lee SE,. Comparison of prostate volume measured by transrectal ultrasonography and MRI with the actual prostate volume measured after radical prostatectomy. Urol Int. 2008; 81: 179-185.
13. Lee JS, Chung BH,. Transrectal ultrasound versus magnetic resonance imaging in the estimation of prostate volume as compared with radical prostatectomy specimens. Urol Int. 2007; 78: 323-327.
14. Capitanio U, Suardi N, Briganti A, et al. Influence of obesity on tumour volume in patients with prostate cancer. BJU Int. 2012; 109: 678-684.
15. Overholser S, Nielsen M, Torkko K, et al. Active surveillance is an appropriate management strategy for a proportion of men diagnosed with prostate cancer by PSA testing. [published online 28, 2015 ]. J Urol. doi: 10.1016/j.juro.2015.01.089.
16. Zhou M, Hayasaka S, Taylor JM, et al. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy. J Urol. 2001; 166: 2193-2197.
17. Davidson DD, Koch MO, Lin H, Jones TD, Biermann K, Cheng L,. Does the size matter? Prostate weight does not predict PSA recurrence after radical prostatectomy. Am J Clin Pathol. 2010; 133: 662-668.